Cover Image
市場調查報告書

北美的髖關節置換市場未來展望

North America Hip Reconstruction Market Outlook to 2021

出版商 GlobalData 商品編碼 294539
出版日期 內容資訊 英文 168 Pages
訂單完成後即時交付
價格
Back to Top
北美的髖關節置換市場未來展望 North America Hip Reconstruction Market Outlook to 2021
出版日期: 2015年08月07日 內容資訊: 英文 168 Pages
簡介

本報告提供北美(美國·加拿大·墨西哥)的髖關節置換市場現狀與未來發展預測分析,提供整體市場規模(以金額·數量為準)的實際成果值·預測值,及各國·各部門的詳細趨勢,市場價格趨勢,市場佔有率現況,再加上主要企業的概要與策略,開發中的產品,最新的市場動靜(資本交易等)等調查,並將結果概述為以下內容。

第1章 目錄

第2章 簡介

第3章 北美的髖關節置換市場

  • 市場概要
  • 市場收益額的類別間比較(總計16年份)
  • 市場收益額的實際成果值(過去8年份)
  • 市場收益額的預測值(今後9年份)
  • 市場規模(以數量為準)趨勢(總計16年份)
  • 市場規模的實際成果值(過去8年份)
  • 市場規模的預測值(今後9年份)
  • 各企業的市場佔有率(以收益為準)

第4章 加拿大的髖關節置換市場

  • 市場收益額的實際成果值:過去8年份
  • 市場收益額的預測值:今後9年份
    • 髖關節完全置換的市場收益額(各領域,過去8年份)
    • 髖關節完全置換的市場收益額(各領域,今後9年份)
  • 市場規模(以數量為準)的實際成果值:過去8年份
  • 市場規模(以數量為準)的預測值:今後9年份
    • 髖關節完全置換的市場規模(各領域,過去8年份)
    • 髖關節完全置換的市場規模(各領域,今後9年份)
  • 平均價格趨勢:總計16年份
  • 流通佔有率(以收益為準)
  • 企業佔有率(以收益為準)

第5章 墨西哥的髖關節置換市場

第6章 美國的髖關節置換市場

第7章 主要企業概要

  • DePuy Companies
  • Stryker Corporation
  • Zimmer Holdings, Inc.
  • Biomet, Inc.
  • Smith & Nephew Plc
  • Wright Medical Group, Inc.

第8章 開發中產品

第9章 近幾年趨勢

  • 企業溝通(全14件)
  • 財務相關資訊(全26件)
  • 政府·公益相關資訊(全14件)
  • 法律規章相關趨勢(全12件)
  • 其他重要的動向(全4件)
  • 產品資訊(1件)
  • 策略·產業計畫資訊(全2件)

第10章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECR0274DB

GlobalData's new report, "North America Hip Reconstruction Market Outlook to 2021", provides key market data on the North America Hip Reconstruction market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Primary Hip Replacement, Revision Hip Replacement, Partial Hip Replacement and Hip Resurfacing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country/region, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Hip Reconstruction market segments - Primary Hip Replacement, Revision Hip Replacement, Partial Hip Replacement and Hip Resurfacing.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Hip Reconstruction market.
  • Global corporate-level profiles of key companies operating within the North America Hip Reconstruction market.
  • Key players covered include Zimmer Holdings, Inc., Stryker Corporation, DePuy Companies, Smith & Nephew Plc, Biomet, Inc. and Wright Medical Group, Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Hip Reconstruction Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Hip Reconstruction Market, North America

  • 3.1. Hip Reconstruction Market, North America, Revenue ($m), 2007-2021
  • 3.2. Hip Reconstruction Market, North America, Category Comparison by Revenue ($m), 2007-2021
  • 3.3. Hip Reconstruction Market, North America, Revenue ($m), 2007-2014
  • 3.4. Hip Reconstruction Market, North America, Revenue ($m), 2014-2021
  • 3.5. Hip Reconstruction Market, North America, Volume (Units), 2007-2021
  • 3.6. Hip Reconstruction Market, North America, Volume (Units), 2007-2014
  • 3.7. Hip Reconstruction Market, North America, Volume (Units), 2014-2021
  • 3.8. Hip Reconstruction Market, North America, Company Share by Revenue ($m), 2014

4. Hip Reconstruction Market, Canada

  • 4.1. Hip Reconstruction Market, Canada, Revenue ($m), 2007-2014'
  • 4.2. Hip Reconstruction Market, Canada, Revenue ($m), 2014-2021
    • 4.2.1. Primary Hip Replacement Market, Canada, Revenue ($m), by Segment, 2007-2014
    • 4.2.2. Primary Hip Replacement Market, Canada, Revenue ($m), by Segment, 2014-2021
  • 4.3. Hip Reconstruction Market, Canada, Volume (Units), 2007-2014
  • 4.4. Hip Reconstruction Market, Canada, Volume (Units), 2014-2021
    • 4.4.1. Primary Hip Replacement Market, Canada, Volume (Units), by Segment, 2007-2014
    • 4.4.2. Primary Hip Replacement Market, Canada, Volume (Units), by Segment, 2014-2021
  • 4.5. Hip Reconstruction Market, Canada, Average Price ($), 2007-2021
  • 4.6. Hip Reconstruction Market, Canada, Distribution Share by Revenue ($m), 2013-2014
  • 4.7. Hip Reconstruction Market, Canada, Company Share by Revenue ($m), 2014

5. Hip Reconstruction Market, Mexico

  • 5.1. Hip Reconstruction Market, Mexico, Revenue ($m), 2007-2014
  • 5.2. Hip Reconstruction Market, Mexico, Revenue ($m), 2014-2021
    • 5.2.1. Primary Hip Replacement Market, Mexico, Revenue ($m), by Segment, 2007-2014
    • 5.2.2. Primary Hip Replacement Market, Mexico, Revenue ($m), by Segment, 2014-2021
  • 5.3. Hip Reconstruction Market, Mexico, Volume (Units), 2007-2014
  • 5.4. Hip Reconstruction Market, Mexico, Volume (Units), 2014-2021
    • 5.4.1. Primary Hip Replacement Market, Mexico, Volume (Units), by Segment, 2007-2014
    • 5.4.2. Primary Hip Replacement Market, Mexico, Volume (Units), by Segment, 2014-2021
  • 5.5. Hip Reconstruction Market, Mexico, Average Price ($), 2007-2021
  • 5.6. Hip Reconstruction Market, Mexico, Distribution Share by Revenue ($m), 2013-2014
  • 5.7. Hip Reconstruction Market, Mexico, Company Share by Revenue ($m), 2014

6. Hip Reconstruction Market, United States

  • 6.1. Hip Reconstruction Market, United States, Revenue ($m), 2007-2014
  • 6.2. Hip Reconstruction Market, United States, Revenue ($m), 2014-2021
    • 6.2.1. Partial Hip Replacement Market, United States, Revenue ($m), by Segment, 2007-2014
    • 6.2.2. Primary Hip Replacement Market, United States, Revenue ($m), by Segment, 2007-2014
    • 6.2.3. Partial Hip Replacement Market, United States, Revenue ($m), by Segment, 2014-2021
    • 6.2.4. Primary Hip Replacement Market, United States, Revenue ($m), by Segment, 2014-2021
  • 6.3. Hip Reconstruction Market, United States, Volume (Units), 2007-2014
  • 6.4. Hip Reconstruction Market, United States, Volume (Units), 2014-2021
    • 6.4.1. Partial Hip Replacement Market, United States, Volume (Units), by Segment, 2007-2014
    • 6.4.2. Primary Hip Replacement Market, United States, Volume (Units), by Segment, 2007-2014
    • 6.4.3. Partial Hip Replacement Market, United States, Volume (Units), by Segment, 2014-2021
    • 6.4.4. Primary Hip Replacement Market, United States, Volume (Units), by Segment, 2014-2021
  • 6.5. Hip Reconstruction Market, United States, Average Price ($), 2007-2021
  • 6.6. Hip Reconstruction Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 6.7. Hip Reconstruction Market, United States, Company Share by Revenue ($m), 2014

7. Overview of Key Companies in North America Hip Reconstruction Market

  • 7.1. DePuy Companies
    • 7.1.1. Company Overview
  • 7.2. Stryker Corporation
    • 7.2.1. Company Overview
  • 7.3. Zimmer Biomet Holdings, Inc.
    • 7.3.1. Company Overview
  • 7.4. Smith & Nephew Plc
    • 7.4.1. Company Overview
  • 7.5. Biomet, Inc. (Inactive)
    • 7.5.1. Company Overview
  • 7.6. MicroPort Scientific Corporation
    • 7.6.1. Company Overview
  • 7.7. DJO Finance LLC
    • 7.7.1. Company Overview

8. Hip Reconstruction Market Pipeline Products

9. Recent Developments

  • 9.1. Corporate Communications
    • 9.1.1. Feb 17, 2015: Memorial Health Increases CT Exam Safety and Efficacy with Toshiba's Aquilion ONE
    • 9.1.2. Dec 12, 2014: Zimmer Holdings Names Michael Farrell to Board of Directors
    • 9.1.3. Dec 04, 2014: Brainsway Receives CE Approval for Deep TMS System - OCD
    • 9.1.4. Oct 13, 2014: Amedica Announces Unexpected Passing of Former Chairman of the Board Max E. Link, Ph.D.
    • 9.1.5. Oct 07, 2014: Amedica Appoints Eric A. Stookey to the Board of Directors
    • 9.1.6. Sep 30, 2014: Amedica Appoints New President and Chief Executive Officer
    • 9.1.7. Sep 29, 2014: AHS Leader Wright Lassiter New President of Henry Ford Health System
    • 9.1.8. Sep 29, 2014: Amedica Appoints New Vice President of Business Development
    • 9.1.9. Sep 15, 2014: Wright Medical Group, Inc. Appoints Kevin D. Cordell as President, U.S. Extremities
  • 9.2. Financial Announcements
    • 9.2.1. Jul 30, 2015: Zimmer Biomet Reports Second Quarter 2015 Financial Results
    • 9.2.2. Jul 28, 2015: Exactech Q2 2015 Revenue $61.5 Million. Net Income $3.7 Million. Diluted EPS $0.26.
    • 9.2.3. Jul 27, 2015: Amedica Announces Preliminary Q2 2015 Financial Results and Update on Recent FDA Response
    • 9.2.4. Jul 23, 2015: Stryker Reports Second Quarter 2015 Results
    • 9.2.5. May 18, 2015: Intra-Cellular Therapies Announces Further Analyses of the Phase 2 Clinical Trial of ITI-007 in Schizophrenia at the 168th Annual Meeting of the American Psychiatric Association
    • 9.2.6. May 07, 2015: Amedica Reports First Quarter 2015 Financial Results
    • 9.2.7. Apr 30, 2015: Zimmer Holdings Reports First Quarter 2015 Financial Results
    • 9.2.8. Apr 28, 2015: Exactech Q1 Revenue $61.4 Million. Net Income Down 2% to $4.1 Million. Diluted EPS $0.29 vs. $0.30.
    • 9.2.9. Apr 21, 2015: Stryker Reports First Quarter 2015 Results
    • 9.2.10. Apr 09, 2015: Biomet Announces Third Quarter of Fiscal Year 2015 Financial Results
    • 9.2.11. Mar 12, 2015: Cynata Therapeutics Commences Further Stage of Stem Cell Manufacturing Program
    • 9.2.12. Mar 05, 2015: Amedica Reports Fourth Quarter and Full Year 2014 Financial Results
    • 9.2.13. Feb 24, 2015: Zimmer Holdings Announces Quarterly Dividend for First Quarter of 2015
    • 9.2.14. Feb 17, 2015: Exactech 2014 Revenue Up 5% to $248.4 Million, Net Income Up 7% to $16.5 Million, EPS $1.18
    • 9.2.15. Feb 11, 2015: Stryker Declares a 13% Increase in Quarterly Dividend
    • 9.2.16. Jan 29, 2015: Zimmer Holdings Reports Fourth Quarter and Full Year 2014 Financial Results
    • 9.2.17. Jan 27, 2015: Stryker Reports 2014 Results
    • 9.2.18. Jan 13, 2015: Stryker Provides 2014 Preliminary Results and Updates 2015 Foreign Exchange Outlook
    • 9.2.19. Jan 06, 2015: Biomet Announces Second Quarter of Fiscal Year 2015 Financial Results
    • 9.2.20. Dec 23, 2014: Repro Med Systems Announces Strong Results for Third Quarter Ended November 30, 2014
    • 9.2.21. Dec 18, 2014: Amedica Announces Preliminary Q4 & FY 2014 Financial Results and Update on CASCADE Clinical Study
    • 9.2.22. Dec 15, 2014: Zimmer Holdings Announces Quarterly Dividend for Fourth Quarter of 2014
    • 9.2.23. Dec 04, 2014: Ra Pharmaceuticals Announces Presentation of Data Supporting Clinical Development of Novel Complement C5 Inhibitor at 2014 ASH Annual Meeting
    • 9.2.24. Dec 03, 2014: Stryker Declares a 13% Increase in Quarterly Dividend
    • 9.2.25. Nov 06, 2014: Amedica Reports Third Quarter 2014 Financial Results
    • 9.2.26. Nov 06, 2014: Tornier Reports Third Quarter 2014 Results
    • 9.2.27. Nov 05, 2014: Wright Medical Group, Inc. Reports 2014 Third Quarter Financial Results and Updated Guidance
    • 9.2.28. Oct 23, 2014: Pfizer Wins SUTENT Patent Case In Delaware District Court
    • 9.2.29. Oct 23, 2014: Zimmer Holdings Reports Third Quarter 2014 Financial Results
    • 9.2.30. Oct 21, 2014: Exactech Q3 Revenue Up 4% to $57.9 Million; Net Income Down 6% to $3.0 Million Due to Currency Losses; Q3 Diluted EPS $0.21 vs. $0.23
    • 9.2.31. Oct 16, 2014: Stryker Reports Third Quarter 2014 Results and 2014 Outlook
    • 9.2.32. Oct 14, 2014: MOLOGEN AG presents EnanDIM: A new generation of immunomodulators
    • 9.2.33. Oct 09, 2014: Biomet Announces First Quarter of Fiscal Year 2015 Financial Results
    • 9.2.34. Aug 07, 2014: Amedica Reports Second Quarter 2014 Financial Results
    • 9.2.35. Aug 05, 2014: Wright Medical Group, Inc. Reports 2014 Second Quarter Financial Results
  • 9.3. Government and Public Interest
    • 9.3.1. Jul 09, 2015: CMS proposes major initiative for hip and knee replacements
  • 9.4. Legal And Regulatory
    • 9.4.1. Jun 13, 2015: Wright Medical Technology Loses In Profemur R Hip Device Lawsuit
    • 9.4.2. Dec 15, 2014: FDA Issues Warning Letter To Signal Medical
    • 9.4.3. Oct 31, 2014: Biomet to Pay Over $6 Million to Resolve Whistleblower Claims That It Paid Kickbacks to Doctors
    • 9.4.4. Oct 29, 2014: Biomet Companies to Pay Over $6 Million to Resolve False Claims Act Allegations Concerning Bone Growth Stimulators
  • 9.5. Other Significant Developments
    • 9.5.1. Mar 25, 2015: Mental Health Disorders Complicate Standards Readmissions
    • 9.5.2. Mar 23, 2015: Federally Funded Project Establishes First National Database of Comprehensive Benchmarks for Total Hip and Knee Joint Replacement
    • 9.5.3. Feb 10, 2015: Drug targeting Ebola virus protein VP24 shows promise in monkeys
    • 9.5.4. Dec 23, 2014: Micron Products Announces Exclusive Agreement With New Era Orthopaedics
    • 9.5.5. Nov 19, 2014: Oxford Performance Materials Receives Prestigious National Institutes Of Health Grant To Improve Treatment Of Infections Related To Artificial Hips, Knees And Other Implanted Devices
    • 9.5.6. Aug 26, 2014: Zimmer Holdings Announces Quarterly Dividend for Third Quarter of 2014
    • 9.5.7. Aug 21, 2014: Stryker Declares a $0.305 Quarterly Dividend July 2014
  • 9.6. Product News
    • 9.6.1. Aug 22, 2014: Advanced Hip Replacement Solutions from Zimmer Offer Once In A Lifetime Technology
  • 9.7. Strategy And Business Planning
    • 9.7.1. Apr 15, 2015: Motif Gains FDA Agreement To Enter Phase 3 Clinical Development With Iclaprim
    • 9.7.2. Jan 20, 2015: InterMed Resources and Amedica Announce Agreement With HealthTrust
    • 9.7.3. Jan 16, 2015: ZIMMER expands Irish Manufacturing presence
    • 9.7.4. Jan 12, 2015: Amedica Announces Steps to Simplify Organization and Align Financial Objectives
    • 9.7.5. Oct 30, 2014: Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing Of The Biomet Transaction
    • 9.7.6. Sep 23, 2014: Stryker plans to construct new Innovation Centre in Cork

10. Appendix

  • 10.1. Research Methodology
    • 10.1.1. Coverage
    • 10.1.2. Secondary Research
    • 10.1.3. Primary Research
    • 10.1.4. Market Modeling and Forecasting
    • 10.1.5. Company Share Analysis
    • 10.1.6. Distribution Share Analysis
  • 10.2. Expert Panel
  • 10.3. GlobalData Consulting
  • 10.4. Contact Us
  • 10.5. Disclaimer

List of Tables

  • Table 1: Hip Reconstruction Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021
  • Table 2: Hip Reconstruction Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 3: Hip Reconstruction Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014
  • Table 4: Hip Reconstruction Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Table 5: Hip Reconstruction Market, North America, Volume (Units), 2007-2021
  • Table 6: Hip Reconstruction Market, North America, Volume (Units), Historic, 2007-2014
  • Table 7: Hip Reconstruction Market, North America, Volume (Units), Forecast, 2014-2021
  • Table 8: Hip Reconstruction Market, North America, Company Share by Revenue ($m), USD Constant, 2014
  • Table 9: Hip Reconstruction Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 10: Hip Reconstruction Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 11: Primary Hip Replacement Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 12: Primary Hip Replacement Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 13: Hip Reconstruction Market, Canada, Volume (Units), Historic, 2007-2014
  • Table 14: Hip Reconstruction Market, Canada, Volume (Units), Forecast, 2014-2021
  • Table 15: Primary Hip Replacement Market, Canada, Volume (Units), Historic, 2007-2014
  • Table 16: Primary Hip Replacement Market, Canada, Volume (Units), Forecast, 2014-2021
  • Table 17: Hip Reconstruction Market, Canada, Average Price ($), Historic, 2007-2014
  • Table 18: Hip Reconstruction Market, Canada, Average Price ($), Forecast, 2014-2021
  • Table 19: Hip Reconstruction Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 20: Hip Reconstruction Market, Canada, Company Share by Revenue ($m), USD Constant, 2013-2014
  • Table 21: Hip Reconstruction Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 22: Hip Reconstruction Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 23: Primary Hip Replacement Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 24: Primary Hip Replacement Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 25: Hip Reconstruction Market, Mexico, Volume (Units), Historic, 2007-2014
  • Table 26: Hip Reconstruction Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Table 27: Primary Hip Replacement Market, Mexico, Volume (Units), Historic, 2007-2014
  • Table 28: Primary Hip Replacement Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Table 29: Hip Reconstruction Market, Mexico, Average Price ($), Historic, 2007-2014
  • Table 30: Hip Reconstruction Market, Mexico, Average Price ($), Forecast, 2014-2021
  • Table 31: Hip Reconstruction Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 32: Hip Reconstruction Market, Mexico, Company Share by Revenue ($m), USD Constant, 2013-2014
  • Table 33: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 34: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 35: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 36: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 37: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 38: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 39: Hip Reconstruction Market, United States, Volume (Units), Historic, 2007-2014
  • Table 40: Hip Reconstruction Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 41: Partial Hip Replacement Market, United States, Volume (Units), Historic, 2007-2014
  • Table 42: Primary Hip Replacement Market, United States, Volume (Units), Historic, 2007-2014
  • Table 43: Partial Hip Replacement Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 44: Primary Hip Replacement Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 45: Hip Reconstruction Market, United States, Average Price ($), Historic, 2007-2014
  • Table 46: Hip Reconstruction Market, United States, Average Price ($), Forecast, 2014-2021
  • Table 47: Hip Reconstruction Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 48: Hip Reconstruction Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 49: Hip Reconstruction Market Pipeline Products
  • Table 50: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

  • Figure 1: Hip Reconstruction Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: Hip Reconstruction Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 3: Hip Reconstruction Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014
  • Figure 4: Hip Reconstruction Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Figure 5: Hip Reconstruction Market, North America, Volume (Units), 2007-2021
  • Figure 6: Hip Reconstruction Market, North America, Volume (Units), Historic, 2007-2014
  • Figure 7: Hip Reconstruction Market, North America, Volume (Units), Forecast, 2014-2021
  • Figure 8: Hip Reconstruction Market, North America, Company Share (%) 2014
  • Figure 9: Hip Reconstruction Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 10: Hip Reconstruction Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 11: Primary Hip Replacement Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 12: Primary Hip Replacement Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 13: Hip Reconstruction Market, Canada, Volume (Units), Historic, 2007-2014
  • Figure 14: Hip Reconstruction Market, Canada, Volume (Units), Forecast, 2014-2021
  • Figure 15: Primary Hip Replacement Market, Canada, Volume (Units), Historic, 2007-2014
  • Figure 16: Primary Hip Replacement Market, Canada, Volume (Units), Forecast, 2014-2021
  • Figure 17: Hip Reconstruction Market, Canada, Company Share (%) 2014
  • Figure 18: Hip Reconstruction Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 19: Hip Reconstruction Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 20: Primary Hip Replacement Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 21: Primary Hip Replacement Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 22: Hip Reconstruction Market, Mexico, Volume (Units), Historic, 2007-2014
  • Figure 23: Hip Reconstruction Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Figure 24: Primary Hip Replacement Market, Mexico, Volume (Units), Historic, 2007-2014
  • Figure 25: Primary Hip Replacement Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Figure 26: Hip Reconstruction Market, Mexico, Company Share (%) 2014
  • Figure 27: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 28: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 29: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 30: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 31: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 32: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 33: Hip Reconstruction Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 34: Hip Reconstruction Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 35: Partial Hip Replacement Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 36: Primary Hip Replacement Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 37: Partial Hip Replacement Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 38: Primary Hip Replacement Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 39: Hip Reconstruction Market, United States, Company Share (%) 2014
  • Figure 40: GlobalData Epidemiology-Based Forecasting Model
  • Figure 41: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 42: Primary Interviews by Participant Type (%)
Back to Top